How much caffeine is in Bourbon Red Coffee compared to regular arabica?

Bourbon Red Coffee contains approximately 18.5 mg of caffeine per gram on a dry weight basis, which falls within the typical range for Coffea arabica varieties (10-20 mg/g). This means a standard 10-gram serving of ground Bourbon Red Coffee delivers roughly 185 mg of caffeine, comparable to a strong 8-ounce drip coffee. No published comparative studies have directly measured Bourbon Red against other named arabica cultivars under identical conditions.

Are there any proven health benefits specific to Bourbon Red Coffee?

No clinical trials have been conducted exclusively on the Bourbon Red cultivar, so no health benefits can be attributed specifically to this variety based on current research. Its effects are extrapolated from the broader Coffea arabica literature, which includes cohort and observational data linking coffee consumption to reduced type 2 diabetes risk and neuroprotective associations. Until cultivar-specific RCTs are published, any claimed benefits unique to Bourbon Red remain speculative.

What compounds in Bourbon Red Coffee affect energy and alertness?

The primary compound responsible for alertness in Bourbon Red Coffee is caffeine, present at 18.5 mg/g dry weight, which blocks adenosine A1 and A2A receptors to suppress fatigue signaling and elevate dopamine and norepinephrine activity. Coffea arabica also contains theobromine and theophylline in smaller quantities, which contribute mild bronchodilatory and stimulant effects. Chlorogenic acids add antioxidant activity but do not meaningfully contribute to the acute energy response.

Is Bourbon Red Coffee safe during pregnancy?

Bourbon Red Coffee is not specifically contraindicated during pregnancy, but its caffeine content of approximately 185 mg per 10-gram serving means pregnant individuals must carefully monitor total daily caffeine intake. Major health authorities including the WHO and ACOG recommend limiting caffeine to under 200 mg per day during pregnancy, as higher intakes are associated with increased risk of low birth weight and miscarriage in epidemiological studies. Decaffeinated alternatives should be considered if caffeine intake is already near the recommended threshold from other dietary sources.

Does Bourbon Red Coffee interact with any medications?

Yes, the caffeine in Bourbon Red Coffee is primarily metabolized by the liver enzyme CYP1A2, meaning medications that inhibit this enzyme—such as ciprofloxacin, fluvoxamine, and some oral contraceptives—can significantly raise plasma caffeine levels and increase side effect risk. Caffeine also antagonizes the effects of adenosine-based drugs used in cardiac stress testing and can reduce the efficacy of certain sedatives and anxiolytics. Individuals taking MAOIs, blood thinners like warfarin, or beta-blockers should consult a healthcare provider before regular consumption, as caffeine can alter drug metabolism and cardiovascular parameters.

What makes Bourbon Red Coffee different from other arabica coffee varieties?

Bourbon Red is a specific cultivar of Coffea arabica known for its distinctive red cherry color and flavor profile, originating from the Bourbon Island variety. It differs from other arabica varieties in its plant morphology, bean characteristics, and organoleptic properties, though caffeine content remains similar to standard arabica at approximately 18.5 mg/g on a dry weight basis. The primary differences are in taste, aroma, and agricultural characteristics rather than nutritional composition.

Can Bourbon Red Coffee be used as a natural food source instead of supplements?

Yes, Bourbon Red Coffee can be consumed as a whole food product through brewed coffee, which provides caffeine and coffee compounds in their naturally occurring matrix. As a food source, it offers the advantage of bioavailability through the complete coffee plant material rather than isolated extracts. This makes it a practical alternative for those seeking caffeine and coffee-derived compounds through dietary intake rather than supplemental forms.

Is there clinical research comparing Bourbon Red Coffee to other coffee cultivars?

Currently, there are no published clinical trials or meta-analyses specifically comparing Bourbon Red Coffee to other arabica cultivars or robusta coffee. Most research on coffee health effects uses unspecified or mixed arabica varieties, making it difficult to isolate effects unique to the Bourbon Red cultivar. Additional research would be needed to determine if this specific variety offers distinct benefits compared to other coffee types.

Bourbon Red Coffee (Coffea arabica)

Bourbon Red Coffee (Coffea arabica) is a rare heirloom cultivar containing approximately 18.5 mg/g caffeine on a dry weight basis, acting primarily as an adenosine receptor antagonist to promote wakefulness and alertness. Unlike broadly studied coffee varieties, Bourbon Red lacks cultivar-specific clinical trials, so its effects are extrapolated from the general Coffea arabica evidence base.

Category: Other Evidence: 2/10 Tier: Traditional

Bourbon Red Coffee (Coffea arabica) — Hermetica Encyclopedia

Origin & History

Bourbon Red Coffee (Coffea arabica) is a premium coffee cultivar grown at high altitudes (1,000-1,800 meters) in volcanic soils, particularly in regions like Rwanda. This variety is characterized by its red cherries when ripe and is known for producing beans with excess glucose, resulting in a smoother, fuller-bodied cup with distinctive caramel and fruit notes.

Historical & Cultural Context

The research dossier provides no information about traditional or historical medicinal use of Bourbon Red Coffee. Sources focus exclusively on agricultural cultivation and flavor profiles rather than therapeutic applications.

Health Benefits

• No clinical health benefits documented in the provided research
• Contains 18.5 mg/g caffeine (dry weight basis) - general caffeine effects not clinically studied in this cultivar
• No specific therapeutic applications found in the research dossier
• No meta-analyses or RCTs available for this specific cultivar
• No traditional medicinal uses documented in the sources

How It Works

Caffeine, the primary bioactive in Bourbon Red Coffee at 18.5 mg/g dry weight, competitively antagonizes adenosine A1 and A2A receptors in the central nervous system, inhibiting adenosine-mediated neuronal inhibition and thereby elevating dopamine and norepinephrine signaling. This receptor blockade also inhibits phosphodiesterase enzymes, increasing intracellular cyclic AMP (cAMP) and amplifying adrenergic activity. Chlorogenic acids present in Coffea arabica cultivars additionally inhibit glucose-6-phosphatase and modulate PPAR-gamma pathways, contributing to observed glucose metabolism effects seen in the broader arabica evidence base.

Scientific Research

The research dossier contains no clinical trials, randomized controlled trials, or meta-analyses specific to Bourbon Red Coffee. The only quantitative data provided is the caffeine content of 18.5 mg/g on a dry weight basis, which appears to be from agricultural rather than clinical sources.

Clinical Summary

No randomized controlled trials or meta-analyses have been conducted specifically on the Bourbon Red cultivar of Coffea arabica, making cultivar-specific efficacy claims unsupported by direct clinical evidence. General Coffea arabica research, including large cohort studies of 100,000-plus participants, associates regular coffee consumption with reduced risk of type 2 diabetes and Parkinson's disease, but these findings cannot be attributed exclusively to Bourbon Red. The caffeine content of 18.5 mg/g dry weight aligns with typical arabica ranges, suggesting its acute stimulant pharmacology mirrors that documented in caffeine-specific RCTs showing improved reaction time and reduced perceived fatigue at doses of 3-6 mg/kg body weight. Overall, the evidence strength for Bourbon Red specifically is very low, rated as insufficient by current standards.

Nutritional Profile

Bourbon Red Coffee (Coffea arabica) green bean compositional data based on available coffee science literature: Caffeine: 18.5 mg/g dry weight (confirmed from research dossier) — notably moderate-to-high for an arabica cultivar. Chlorogenic acids (CGAs): estimated 60–120 mg/g dry weight, predominantly 5-caffeoylquinic acid (5-CQA), 3-CQA, and 4-CQA; these are the dominant bioactive polyphenols in arabica green beans and are substantially degraded (40–70% loss) during roasting. Trigonelline: approximately 10–12 mg/g dry weight in green arabica beans; degrades to niacin (vitamin B3) during roasting at rates proportional to roast degree. Sucrose: approximately 60–90 mg/g dry weight in green beans; nearly fully degraded during roasting via Maillard reactions and caramelization. Lipids (coffee oil): approximately 150–170 mg/g dry weight in arabica green beans, rich in diterpenes cafestol and kahweol (bioavailability is filter-dependent — paper filtration removes >90% of diterpenes). Protein: approximately 100–130 mg/g dry weight in green beans; Maillard reaction reduces free amino acid content significantly post-roast. Potassium: approximately 1,600–2,000 mg per 100g dry weight — primary mineral in brewed coffee. Magnesium: approximately 150–200 mg per 100g dry weight. Niacin (B3): formed de novo from trigonelline degradation during roasting; brewed coffee contributes approximately 0.5–1.0 mg per 150 ml cup. Riboflavin (B2): trace levels, approximately 0.01–0.02 mg per 100g green bean. Fiber (as melanoidins in roasted form): 1–3 mg/ml in brewed coffee; melanoidins are high-molecular-weight Maillard products with prebiotic potential. Cultivar-specific compositional data beyond caffeine content (18.5 mg/g) is not independently documented in the provided research dossier; all other values are extrapolated from general Coffea arabica green bean literature and should be considered approximations pending cultivar-specific analysis.

Preparation & Dosage

No clinically studied dosage ranges are available in the research dossier. The only quantitative information is caffeine content at 18.5 mg/g dry weight. No standardized extracts or therapeutic preparations are documented. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients documented in research

Safety & Interactions

Caffeine from Bourbon Red Coffee can cause dose-dependent side effects including tachycardia, anxiety, insomnia, and elevated blood pressure, particularly at intakes exceeding 400 mg caffeine per day in healthy adults per FDA guidance. It interacts significantly with adenosine-based medications, monoamine oxidase inhibitors (MAOIs), and anticoagulants such as warfarin by altering CYP1A2-mediated hepatic metabolism. Pregnant individuals are advised to limit total caffeine intake to under 200 mg per day due to associations with low birth weight and preterm delivery observed in epidemiological data. Individuals with cardiac arrhythmias, anxiety disorders, or uncontrolled hypertension should consult a physician before regular consumption.